chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 16 week old patient who on 06 Nov 2006 was vaccinated with a first dose of Rotateq (human bovine) (lot # 653915/0389F). No symptoms were reported. There was no product quality complaint involved. Additional information has been requested.
had a sore arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (had a sore arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (had a sore arm). At the time of the report, PAIN IN EXTREMITY (had a sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The treatment history was not reported. The concomitant medication was not reported.   This case was linked to MOD-2021-292156 (Patient Link).
headache, sore throat, runny nose, arm pain that migrated to the axilla and down the side of the body, joint pain ( hands, wrist, feet, hips, knees, spine, neck), insomnia, general malaise, fatigue, and lower grade fever. Most symptoms lasted about 7 -10 days. However, it is now day 20 after the initial vaccine and I still have joint pain that has not gone away. esp in hands, wrists, and feet. When I sleep I still wake up with all my joints hurting it gets better as I start moving but the wrist, hands, and feet pain has not gone away. This pain will wake me in the night when I change positions.  I called my doctor today to inquire if it is a good idea if I should take the second dose because the first dose made me so dibiliated. Awaiting for a response. I am due to take the second vaccine on 2/9/21.
Swelling at injection site; pain; deep redness temp oral: 99.9(1-11-13).
Severe neck and left shoulder pain radiating into the area of the injection site on left arm.  Neck stiffness. Being treated with OTC pan medication currently.
pain of the injection site/tenderness of the injection site; fatigue; headache; chills; muscle pain; joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain of the injection site/tenderness of the injection site), FATIGUE (fatigue), HEADACHE (headache), CHILLS (chills) and MYALGIA (muscle pain) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 007M20A and 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Ulcerative colitis, Cholesterol and Blood pressure. Concomitant products included INSULIN for Diabetes.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain of the injection site/tenderness of the injection site), FATIGUE (fatigue), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and NAUSEA (nausea). At the time of the report, VACCINATION SITE PAIN (pain of the injection site/tenderness of the injection site), FATIGUE (fatigue), HEADACHE (headache), CHILLS (chills), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and NAUSEA (nausea) outcome was unknown.            Treatment details not provided.
Swollen upper arm, redness, very warm to the touch , itching,  sore arm muscles (difficulty holding anything using left arm. Pain extends to the wrist.
I don't know if this is known already as I've seen muscle/joint pain listed as a reaction but in addition to chills, aches, fever, I experienced continual, radiating bone pain in my hip and thigh area from about 11:30 am on 4/29/21 until the evening of 4/30/21. As of 5/4/21, I am again feeling pain in my hip/butt area. Tylenol or similar might resolve but I thought it was important to advise this information. My mother-in-law who had her vaccine weeks before me had the same, exact symptom. Sleeping was very helpful in not focusing on the pain. My mother-in-law had the same pain in the same area when she had the vaccine weeks before me.   On a positive note, I did notice that immediately after the 1st vaccine a rash developed on my neck sometime in January (which required me to stop wearing a gold necklace I always wore) went away immediately after the 1st dose of the vaccine. I had tried using several creams and tea tree oil long before the vaccine with little relief. Additionally, I am inclined to believe that when I got VERY sick if back in Feb. 2020 that I probably had Covid resulted in me having Pneumonia. It left me constantly having to clear my throat of mucus and it was so bad early on that I had to use an inhaler and a nebulizer from Feb 2020 until the 1st dose of the vaccine in 2021 when it started to improve. It has improved even more since the 2nd vaccine.
After giving influenza and PNEUMOVAX in separate arms, the pt passed out in her chair. She was caught and kept from injuring herself. She immediately came back to consciousness and said she had not eaten. She was given orange juice while still in chair. Pt stated she felt better. School nurse escorted pt back to classroom where she ate a turkey sandwich. Rechecked on pt 30 min and 1 hour later. She reported feeling fine.
Dry heaves really bad; Dizziness; headache; i'm tired; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired). At the time of the report, RETCHING (Dry heaves really bad), DIZZINESS (Dizziness), HEADACHE (headache) and FATIGUE (i'm tired) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: NNI-Reporter stated she does not have an email address or a faxnumber.
Bilirubin rose to 2.3; fatigue; malaise; Liver biopsy on 12Feb showed cholestasis; This is a spontaneous report from a contactable physician, received via a Pfizer sales representative. A 46-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date unknown), via an unspecified route of administration on 06Feb2021 at a single dose for COVID-19 immunization. Medical history included fatty liver and ulcerative colitis. The patient's concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Jan2021 for COVID-19 immunization. On 12Feb2021, the patient had a liver biopsy which showed cholestasis. On an unknown date, the patient experienced fatigue and malaise, and bilirubin rose to 2.3. The events were resolving.   Information on the batch/lot number has been requested.
PATIENT REPORTS THAT BY EVENING OF THE DAY OF INJECTION, INJECTION SITE FELT HARD, WAS STARTING TO TURN RED, FELT WARM AND WAS PAINFUL. TWO DAYS FOLLOWING INJECTION PATIENT WAS SEEN AND REDNESS HAD PROGRESSED THE ENTIRE LENGTH OF ARM.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date in March 2015 (also reported as "the last month"), the patient was vaccinated with an improperly stored dose of GARDASIL, lot # K005881, expiration date 14-JAN-2017, (dose, dose number, route and anatomical location were unspecified). No concomitant therapies were reported. No adverse effects reported. The outcome of the events was unknown. This is one of several reports received from the same reporter. Additional information is not expected because reporter refused additional contact.
This spontaneous report as received from a medical assistant refers to a no pregnant, 20 year old female patient. The patient's medical history, drug reactions, allergies and concurrent conditions were not reported. In approximately 2007 (when the patient was 11 years old), the patient was vaccinated with a dose of VARIVAX subcutaneous (dose, anatomical location, lot number and expiration date were not reported). In approximately 2016 (reported as at the age of 20), she was also vaccinated with a dose of VARIVAX subcutaneous (dose, anatomical location, lot number and expiration date were not reported). Concomitant therapies were not reported. On 22-JUN-2016, the patient had a lab work which revealed no reactive titers. The patient sought an unspecified medical attention. The outcome of the event was not reported. The relatedness between event and VARIVAX was not reported. Additional information has been requested.
A) Within 8 hours after injection: redness, swelling and pain at injection site (upper right arm); feeling tired.  B) Overnight: swelling and redness continued to spread  from neck to elbow. Swelling of lymph nodes under right arm and right side of neck. Muscle pain in arm, neck and shoulder, migraine. Rash.  C) Over the following 2 days, symptoms continued to worsen: swelling of lymph nodes on both sides of the neck, under left and right arm (right more painful than left) and lymph nodes near pubic area - right side. Excruciating pain in all muscles of the body, particularly neck, head, right side of the torso and right arm. This affected my ability to breathe (shallow breath, unable to take a deep breath).  Mobility extremely reduced for 24 hours (unable to switch from left to right side in bed, unable to sit, get up, walk and grab objects). I had to let myself fall off my bed, then crawled on all 4 to the kitchen to get a glass of water. Eventually, the muscles of my right arm contracted, bringing my right hand almost to the level of my right shoulder.  I remained paralyzed in that position for the next 3 days.  Symptoms started to disappear after 4 days. It took a total of 10 days to recover full mobility of my right arm. Traces of the rash are still visible 5 months after injection.
Full on Flu; Body aches; Weak and sick; Weak and sick; Vertigo; Felt like I wanted to throw up; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick) and VERTIGO (Vertigo) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 154201) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced INFLUENZA (Full on Flu), MYALGIA (Body aches), ASTHENIA (Weak and sick), ILLNESS (Weak and sick), VERTIGO (Vertigo) and NAUSEA (Felt like I wanted to throw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Headache, Angioedema, SWOLLEN FINGERS, LYMPH NODE PAIN, INJECTION SITE PAIN Narrative:
Patient experienced back pain on 9/13/13 following immunization. Also awoke during night/early arm on 9/13-14 with chest tightness. Resolved by 9/14 with no treatment.
Atrial Fibrillation problems since vaccine. Three separate Cardioversions over the past year to get heart back in rhythm since vaccine. Recently in hospital for four days getting treatment to put heart back in correct rhythm.
Hives head to toe minutes after injection. Worse right at varicella site. BENADRYL 12.5mg given, Prednisone 20 mg given. Hives resolved within 10 minutes.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On unspecified dates,the patients were vaccinated with improperly stored RECOMBIVAX HB lot # M045653, expiration date 03-JUL-2019, for prophylaxis. The vaccine was exposed to 32 degree Fahrenheit to 35 degree Fahrenheit for 40 minutes. There was a previous temperature excursion at 32 degree Fahrenheit to 35 degree Fahrenheit for 3 hours 10 minutes. Digital data logger was involved. No adverse effects were reported. There was no product quality complaint(PQC) involved. This is one of the several reports received from same reporter.; Sender's Comments:  US-009507513-1708USA005415: US-009507513-1708USA005627: US-009507513-1708USA005628:
Pt claims to have lockjaw and has visible edema. Claims this has been going on for three weeks. He also claimed he had serious fatigue and fell asleep doing daily tasks.  He states this is interfering with his ability to work as he is "always in a daze." Patient also has had trouble speaking and had visible facial paralysis (but not bilateral facial paralysis).
Low grade fever, extreme chills, joint pain, body aches, headache, onset within 14 hours after administration of vaccine lasting 24 hours
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 17-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant treatment was provided. No treatment medication was provided.
Initial unsolicited report received from a nurse on 09 September 2016. This case involves a female patient (age was not reported) who was vaccinated with a dose of FLUZONE QIV MDV (Batch number, expiration date, dose, route and site of administration was not reported) on an unspecifie date. Patient's ongoing illness, medical history and concomitant medications were not reported. On an unspecified date, post vaccination, patient experiecend allergic reaction, hives and swelling. Laboratory investigations and corrective treatment were not reported. The outcome of the events was not reported. List of documents held by sender: none.
Pt recvd MMR vax in 1983 w/no noted problems & 3JUN91 pt recvd 2nd dose of MMR vax  & that evening exp dizziness, nausea, vomiting, & h/a; tx w/APAP & recovered w/in 24 hrs;
This spontaneous report as received from a healthcare worker, refers to a patient of unknown age and gender. No pertinent medical history,  concurrent conditions or drug reactions/allergies were reported. On 15-MAR-2016, the patient was vaccinated with an improperly stored dose of GARDASIL 9, which had a lot # of L016428 and an expiration date of 30-AUG-2017 (dose, dosage number, route of administration and anatomical location were not reported). It was stated that the temperature excursion was 28.9 for a time frame of 7 hours. This excursion was found due to a data logger. Additionally, it was stated that no previous temperature excursions had occurred. This is one of the several reports received from the same reporter. Additional information has been requested.
flu-like symptoms; joint and muscle pain in hips and back of thighs; joint and muscle pain in hips and back of thighs; headache; bodyaches; fever; lack of appetite; fatigue; weakness; light headedness; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Lot Number: EN5318), via an unspecified route of administration on 09Feb2021 (at the age of 65-years) as 1ST DOSE, SINGLE DOSE in Arm Left for covid-19 immunization. Medical history included: known allergies: Minor Adverse reaction to Yellow Fever Vaccine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. Prior to the vaccination the patient was not diagnosed with COVID-19. On 09Feb2021, the patient experienced 5-7 days of flu-like symptoms: headache, bodyaches, fever, lack of appetite, fatigue, weakness, light headedness. Additionally, the patient had 5-7 days of joint and muscle pain in hips and back of thighs interfering with sleep at night. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the events. On 12Feb2021, post vaccination the patient had nasal swab test (SARS-CoV-2 test) and the result was negative. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Case was initially hospitalized for a ERCT bowel duct stone while traveling in TX (08-05-21 to 08-15-21). Upon returning home, symptom onset was 8/21/2021; symptoms inlcuded fever, cough, runny nose, congestion, fatigue, poor appetite, chills, nausea, diarrhea. Case tested positive for Covid-19 with a PCR test type, on 8/22/21. She was hospitalized at local HCF from 8-25-21to 8-30-21.
Student presented for MMR and PPD.  MMR was given first and patient tolerated it well.  PPD was administered and patient became pale, lightheaded and started to slump forward.  Patient assisted to floor by administering and other nurses.  Doctor came and assessed patient.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 28-Jan-2022) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided.  Patient received booster dose vaccination time was given as 13:16:42. The patient received Moderna vaccine past its 30 day of expiry date. Vaccine went into 2 to 8 degree Celsius thaw state on or about 24-Dec-2021. This vaccine was administered up until its manufacturing expiry date of 04-Apr-2022. We no longer possess this lot number. Treatment medications were not reported.
I had shortness of breath, asthma, within 4 hours of the vaccination.  My arm became very sore and had a red spot the size of a quarter.  There was also a red line which looked like a scratch, 3 inches long, extending toward my armpit.  By the next morning, I had flu like symptoms, headache, aches, soreness, postnasal drip, thick yellow mucus, fever, shortness of breath.  These symptoms lasted 48 hours.  Following these 48 hours, I had no fever. But for the next 10 days, I had terrible breathing difficulties - asthma, thick yellow mucus post nasal drip, wheezing, coughing, coughing up this same mucus, waking up for 7 straight nights unable to breathe.
Developed hives after Fluzone approx 15 minute with administration itchy and stated skin felt hot. Benadryl given in office. Hives resolved approx 8 hours later saw allergist next day.
This nurse was notified that the worker was having tachycardia post vaccination. The worker had a baseline HR of 75 while at rest, per wrist band monitor belonging to worker. Worker's HR steadily increased as high as 94 BPM. The worker was shaking and the worker complained of throat not feeling right and dizziness. Worker described their throat as feeling tight. This nurse brought the worker to the back area of the clinic, asked the observer to initiate a MET, and this nurse went to med room and took an EpiPen from the box. This nurse administered the EpiPen into the right thigh at 1600. by 1604 the MET team had arrived. The MET team spent 20 to 25 minutes with worker. The MET team included two PICU physicians, one being a fellow. This nurse was advised that the worker was asked if wanted to go to the ED (by the worker) and worker declined. This nurse agreed to observe the worker until the close of clinic at 1730. Vitals take at 1720 were as follows: 89 HR, 94% O2 sat, 124/66 BP (RUE), 16RR.  Worker was no longer feeling dizzy, no throat symptoms,  and refused ED observation and went home. Nothing further reported.
A few hours after receiving this vaccine my arms, hands, face, and feet began to tingle and became very sensitive to temperature change (mostly cold.) For example my hands tingled every time I washed my hands. This went on for two days, and seemed to be getting better until I went swimming one day. I was outside for 30 minutes when my skin began to have a burning sensation. I immediately got out of the sun, but this sensation persisted. My hands and feet ended up burning/blistering from the sun exposure and the burning sensation lasted for two days. I am in veterinary school and really need to receive this vaccine for pre-exposure and plan on trying to get this series again. I am just wondering if there have been any reactions similar to this or if there is any other information that would be beneficial.
Pt recvd vax 30OCT91, started devel pain/tingling in hands & feet approx 1 wk p/vax; progressive weakness.Pt fell X2. Bilateral & symetrical weakness; primarly affected extremities never intubated; dec EMG's; plasmapheresis;
Information has been received from a physician concerning a 19 year old female who on 08-Jan-2007 was vaccinated with Gardasil (yeast) (lot number 655165/1425F) 0.5 ml intramuscularly. On 10-JAN-2007 the patient experienced 102 degrees F fever, chills and body aches for "the past 10 hours". The patient's 102 degrees F fever and chills and body aches persisted. Additional information has been requested.